Liminal BioSciences

YTD

ALL

Why Robinhood?

You can watch LMNL and buy or sell other stocks, ETFs, and their options commission-free!

About LMNL

Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach.

CEO

Bruce Philip Pritchard

CEOBruce Philip Pritchard

Employees

—

Employees—

Headquarters

Laval, Québec

HeadquartersLaval, Québec

Founded

1994

Founded1994

Employees

—

Employees—

LMNL Key Statistics

Market cap

19.82M

Market cap19.82M

Price-Earnings ratio

27.62

Price-Earnings ratio27.62

Dividend yield

—

Dividend yield—

Average volume

16.36K

Average volume16.36K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$8.50

52 Week high$8.50

52 Week low

$3.10

52 Week low$3.10

People also own

Based on the portfolios of people who own LMNL. This list is generated using Robinhood data, and it’s not a recommendation.

Cenntro Electric Group Li…

Tilray Brands